-
公开(公告)号:JP2002007379A
公开(公告)日:2002-01-11
申请号:JP2000193074
申请日:2000-06-27
Applicant: NEW IND RES ORGANIZATION
Inventor: NAKAO MUTSUHIKO
Abstract: PROBLEM TO BE SOLVED: To provide a fluctuation signal generating method capable of generating infinite length and various sequences having exact 1/f characteristics. SOLUTION: There are (m) pieces of different states, the probability distribution function of a duration time in a state (i) is defined as F (Kλ), and a transient probability matrix to transmit from the state (i) to a state (j) is defined as P. A transient probability for transiting the component of the probability matrix P from the state (i) to the state (j) and a transient probability from a state m+1-i to a state m+1-j are made equal, components from the second row to the (m-1)th row of the transient probability are distributed while matching the centers of both side symmetric distribution functions W (x) with a diagonal term, and (m) column components of the first row and the m-th row are determined by any one of six types, with which the both side symmetric distribution functions are distributed in different orders. Every time a state transition occurs from an arbitrary initial state, a random number (r) is generated, a duration time K for staying in the state (i) is determined, a semi-Markov process is generated for a transition to the next state (j) by the instruction of another for a transition to the next state (j) by the instruction of another random number (v), and a semi-Markov sequence is generated for extracting an output amplitude applied by X=bi+c corresponding to the state number (i).
-
公开(公告)号:DE602004014733D1
公开(公告)日:2008-08-14
申请号:DE602004014733
申请日:2004-02-17
Applicant: NEW IND RES ORGANIZATION
Inventor: TSUJI SOICHI , MANNEN HIDEYUKI , TANIGUCHI MASAAKI
Abstract: We paid attention to stearoyl-CoA desaturase gene, and investigated the relation between this gene and the unsaturated fatty acid content in beef fat. As a result, we found that the unsaturated fatty acid content was associated with the genotype of this gene, classified according to several single nucleotide polymorphisms (SNPs) on this gene. The present invention is a method to predict the unsaturated fatty acid content in beef (or milk) fat, on the basis of the genotype of bovine stearoyl-CoA desaturase, and useful prediction method for beef quality such as taste and texture.
-
公开(公告)号:CA2596852A1
公开(公告)日:2006-08-10
申请号:CA2596852
申请日:2006-02-03
Applicant: NEW IND RES ORGANIZATION
Inventor: MANNEN HIDEYUKI , TSUJI SOICHI
IPC: C12N15/09 , A01K67/027 , C07K14/47 , C12Q1/68
-
公开(公告)号:CA2542337A1
公开(公告)日:2005-04-28
申请号:CA2542337
申请日:2004-10-15
Applicant: NEW IND RES ORGANIZATION
Inventor: SHIRAKAWA TOSHIRO , HAMADA KATSUYUKI , GOTO AKINOBU
IPC: A61K48/00 , A61K31/409 , A61K33/26 , A61K35/12 , A61K35/13 , A61K35/76 , A61K35/761 , A61K35/763 , A61K35/765 , A61K35/766 , A61K39/12 , A61K47/42 , A61P35/00 , C07K14/475 , C12N15/00 , C12N15/85 , C12N15/861
Abstract: An oncogene therapeutic drug which contains a carrier cell having been infected with an oncolytic virus so as to treat a tumor cell with the virus within the living body. As the carrier cell, any of an A549 cell, a 293 cell , an SW626 cell and an HT-3 cell showing a potent antitumor effect is used. Because of using such a cell having a high antitumor effect both in vitro an d in vivo as the carrier cell, an enhanced antitumor effect can be established compared with conventional carrier cells.
-
公开(公告)号:AU2002354455A1
公开(公告)日:2003-07-09
申请号:AU2002354455
申请日:2002-12-10
Applicant: NEW IND RES ORGANIZATION
Inventor: ASAOKA YASUSHI , SANO NAOKATSU , KANEKO TADAAKI
IPC: H01L21/027 , H01L21/302 , H01L21/308 , H01L21/311
-
公开(公告)号:AU2002354443A1
公开(公告)日:2003-06-17
申请号:AU2002354443
申请日:2002-12-06
Applicant: NEW IND RES ORGANIZATION
Inventor: YOSHINO KENICHI , TOKUNAGA CHIHARU , YONEZAWA KAZUYOSHI , HARA KENTA
-
47.
公开(公告)号:AU7770701A
公开(公告)日:2002-02-18
申请号:AU7770701
申请日:2001-08-06
Applicant: NEW IND RES ORGANIZATION
Inventor: FUKUDA HIDEKI , KONDO AKIHIKO , KURODA SYUNICHI , TANIZAWA KATSUYUKI , TOKUYAMA SHINJI
-
公开(公告)号:GB0121878D0
公开(公告)日:2001-10-31
申请号:GB0121878
申请日:2001-09-10
Applicant: AND IND RES ORGANIZATION , AUTOLIV DEV
Abstract: A safety arrangement comprises a unit 20 to be located beneath a bonnet 8 of a motor vehicle. The unit can become of increase length (fig 5) in response to a signal from a sensor 35 and may comprise a bellows-sleeve 21 and a gas generator 19. The unit has a catch arrangement 23 that engages part 9 of the bonnet structure so that part of the bonnet structure is engaged and retained when the length of the unit is increased. When the front part of a motor vehicle strikes a pedestrian the bonnet 8 is lifted by unit 20 allowing further deformation of the bonnet decreasing the severity of possible injury suffered by the pedestrian.
-
公开(公告)号:GB0121701D0
公开(公告)日:2001-10-31
申请号:GB0121701
申请日:2001-09-07
Applicant: AND IND RES ORGANIZATION , AUTOLIV DEV
IPC: B60R21/16 , B60R21/233 , B60R21/2338 , B60R21/34 , B60R21/36
-
50.
公开(公告)号:JP2006225303A
公开(公告)日:2006-08-31
申请号:JP2005039888
申请日:2005-02-16
Applicant: NEW IND RES ORGANIZATION
Inventor: OISHI YOSHITAKA , KOIDA MASAO
IPC: C07D307/82 , A61K31/343 , A61K31/422 , A61K31/427 , A61K31/5365 , A61K31/675 , A61P3/14 , A61P19/00 , A61P19/02 , A61P19/08 , A61P19/10 , A61P29/00 , C07D413/12 , C07D417/04 , C07D498/04 , C07F9/6533
Abstract: PROBLEM TO BE SOLVED: To enlarge the selection range of treatment by diversifying preventive agents or therapeutic agents of bone metabolism disorder (e.g. osteoporosis, arthritis, chronic arthrorheumatism, arthropathia, osteoarthropathy, Paget's disease, Bechterew's disease and hypercalcemia) by providing a highly safe new-type estrogen-substitutional drug (nonhormonal remedy) having physical restoration activities of the bone similar to the estrogen. SOLUTION: The composition for preventing or treating the bone metabolism disorder contains a compound represented by formula (I) (wherein, each symbol is defined specifically) or a pharmaceutically acceptable salt thereof, or a compound represented by formula (X) (wherein, each symbol is defined specifically) or a pharmaceutically acceptable salt thereof. COPYRIGHT: (C)2006,JPO&NCIPI
-
-
-
-
-
-
-
-
-